Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Prudential Financial Inc — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Prudential Financial Inc trades at $114.86 (market cap $39.15B). The key difference: Prudential Financial Inc is far larger — about 40.1× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Prudential Financial Inc pays a 4.93% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Prudential Financial Inc for 146 Days on average.
| MRVI | PRU | |
|---|---|---|
Market Cap | $977.37M | $39.15B |
Volume | 2,742,564 | 1,633,697 |
Sector | Health | Financials |
52-Week High | $9.00 | $125.13 |
52-Week Low | $2.83 | $92.00 |
Typical Hold Time | 0 Days | 146 Days |
Enterprise Value | $1.08B | $67.93B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Prudential Financial (PRU) trades at $113.41, showing minimal daily movement with a 0.02% gain. The stock presents mixed signals with bearish technical indicators but strong fundamental metrics including a low P/E of 10.28 and solid ROE of 12.46%. Recent earnings show two consecutive beats, while the company executes strategic initiatives including a $185M Alexforbes stake sale and rebranding to Prudential Wealth Advisors.
PRU offers value investment appeal with attractive valuation multiples and consistent profitability, though technical weakness and mixed analyst sentiment (67.57% Hold rating) suggest near-term caution. Key risks include interest rate sensitivity and competitive pressures in the insurance sector, while higher rates could benefit investment income. The consensus price target of $105.56 implies modest downside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
